These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16935455)

  • 21. National survey on the pre-analytical variability in a representative cohort of Italian laboratories.
    Lippi G; Montagnana M; Giavarina D; ; ;
    Clin Chem Lab Med; 2006; 44(12):1491-4. PubMed ID: 17163828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds.
    Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing
    Clin Microbiol Infect; 2008 Oct; 14(10):982-4. PubMed ID: 18828858
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of effectiveness of a continuing education program on antimicrobial susceptibility testing.
    Rosner ER; Mulawski KK; Willis JR; Lipman HB; Boone AS; Hindler JF
    Clin Lab Sci; 2007; 20(3):146-53. PubMed ID: 17691670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluconazole susceptibility testing of Candida species by flow cytometry.
    Joung YH; Kim HR; Lee MK; Park AJ
    J Infect; 2007 May; 54(5):504-8. PubMed ID: 17084902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorimetric broth microdilution method for the antifungal screening of plant extracts against yeasts.
    Liu M; Seidel V; Katerere DR; Gray AI
    Methods; 2007 Aug; 42(4):325-9. PubMed ID: 17560320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Availability of laboratory tools for microbiological diagnosis of lower respiratory tract infections in Italian hospitals].
    Rota MC; D'Ancona F; Cavallaro GM; Bagnato B; Nacca G; Serra R
    Ann Ig; 2007; 19(6):509-17. PubMed ID: 18376571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fungal blood stream infection, its pathogen and antifungal susceptibility in cancer patients].
    Fujihara S; Imataki O; Tamai Y; Kawakami K
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2383-7. PubMed ID: 19098407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: results of a three year survey.
    Fadda ME; Podda GS; Pisano MB; Deplano M; Cosentino S
    J Prev Med Hyg; 2008 Jun; 49(2):69-74. PubMed ID: 18847180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Methods of determining antifungal activity in vitro].
    Kockovská D
    Epidemiol Mikrobiol Imunol; 1994 Sep; 43(3):137-41. PubMed ID: 7953089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program.
    Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ;
    Diagn Microbiol Infect Dis; 2009 Sep; 65(1):27-34. PubMed ID: 19679232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
    Sarifakioglu E; Seçkin D; Demirbilek M; Can F
    Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the 10th External Quality Assessment Scheme results in clinical microbiology laboratories in Tehran and districts.
    Abbassi M; Rahbar M; Hekmat Yazdi S; Rashed Marandi F; Sabourian R; Saremi M
    East Mediterr Health J; 2006; 12(3-4):310-5. PubMed ID: 17037699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2).
    Rodriguez-Tudela JL; Donnelly JP; Pfaller MA; Chryssantou E; Warn P; Denning DW; Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M
    J Clin Microbiol; 2007 Jan; 45(1):109-11. PubMed ID: 17093015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid].
    Mitarai S; Kobayashi I; Abe C; Wada M; Suzuki K; Takashima T; Kawabe Y; Machida K; Tano M; Takigawa S; Kamada A; Shigetoh E; Fujii S; Mori K; Suyama H; Yano S; Kawashiro T; Ogata H
    Kekkaku; 2007 May; 82(5):449-54. PubMed ID: 17564123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular fungal isolates and antifungal susceptibility in northern China.
    Xuguang S; Zhixin W; Zhiqun W; Shiyun L; Ran L
    Am J Ophthalmol; 2007 Jan; 143(1):131-133. PubMed ID: 17188047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Standardization of the fungistasis diffusion test].
    Böhm W
    Dermatol Monatsschr; 1969; 155(7):504-6. PubMed ID: 4989817
    [No Abstract]   [Full Text] [Related]  

  • 37. [External quality assessment of drug susceptibility testing for Mycobacterium tuberculosis].
    Mitarai S; ;
    Kekkaku; 2006 Aug; 81(8):501-9. PubMed ID: 16972653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postantifungal effect methods.
    Vitale RG
    Methods Mol Med; 2005; 118():153-8. PubMed ID: 15888941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between CLSI, EUCAST and Etest methodologies for amphotericin B and fluconazole antifungal susceptibility testing of Candida spp. clinical isolates.
    Claudino AL; Peixoto RF; Melhem MS; Szeszs MW; Lyon JP; Chavasco JK; Franco MC
    Pharmazie; 2008 Apr; 63(4):286-9. PubMed ID: 18468388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features.
    Kim MN; Shin JH; Sung H; Lee K; Kim EC; Ryoo N; Lee JS; Jung SI; Park KH; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
    Clin Infect Dis; 2009 Mar; 48(6):e57-61. PubMed ID: 19193113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.